To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SERTAD4TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
114 supporting clones for gene SERTAD4 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AU253902 neuroblastoma .a 1 to 640 1 to 640   tiling clone,   640/645
(99 %)
4 diff
(99.4 %id)
DA086020 cerebellum .a 6 to 582 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
DA692232   .a 58 to 626 2 to 570   tiling clone, capped   569/569
(100 %)
1 diff
(99.9 %id)
DB298122 cerebellum .a 1500 to 2031 533 to 2   tiling clone,   532/533
(99 %)
0 diff
(100 %id)
CN308416 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1 to 710 1 to 712   tiling clone,   712/712
(100 %)
7 diff
(99.1 %id)
AK315386 corpus callosum .b 314 to 1562 1 to 1249 exact tiling clone,   1249/1249
(100 %)
2 diff
(99.9 %id)
DA274946 corpus callosum .b 315 to 886 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
AI671764 Kidney .c 1 to 214 214 to 1   tiling clone,   214/214
(100 %)
0 diff
(100 %id)
CF993787 Human Placenta, placenta .c 23 to 692 28 to 704       677/866
(78 %)
35 diff
(96.0 %id)
BC012083 Kidney, renal cell adenocarcinoma .c 74 to 2079 1 to 2006 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2006/2006
(100 %)
1 diff
(100.0 %id)
NM_019605.3   .c 74 to 2079 1 to 2006 exact RefSeq, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 2006/2006
(100 %)
0 diff
(100 %id)
AK096381   .c 108 to 2079 1 to 1972 E284G R325G available from FLJ,   1972/1972
(100 %)
2 diff
(99.9 %id)
DA748621   .c 109 to 689 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DR006028 Prostate .c 146 to 727 1 to 582       582/582
(100 %)
7 diff
(98.8 %id)
TI_1948123231   .c 246 to 876 1 to 627   fully sequenced,   627/627
(100 %)
7 diff
(98.9 %id)
CV028617 mixed .c 253 to 917 1 to 663       663/667
(99 %)
6 diff
(99.2 %id)
TI_1948122794   .c 253 to 891 124 to 773   fully sequenced,   650/773
(84 %)
8 diff
(99.0 %id)
TI_1948122932   .c 253 to 785 126 to 660   fully sequenced,   535/660
(81 %)
8 diff
(98.8 %id)
TI_1948123085   .c 253 to 899 122 to 778   fully sequenced,   657/778
(84 %)
8 diff
(99.0 %id)
AI972054 fibrotheoma, ovary .c 270 to 704 1 to 437     Submitted on the opposite strand 437/437
(100 %)
3 diff
(99.4 %id)
BQ216710 melanotic melanoma, skin .c 342 to 956 1 to 616       616/907
(67 %)
3 diff
(99.7 %id)
CR605084 Neuroblastoma Cot 10-normalized .c 593 to 2045 1 to 1453       1453/1453
(100 %)
0 diff
(100 %id)
AL521421 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 593 to 1307 1 to 716   fully sequenced,   716/716
(100 %)
1 diff
(99.9 %id)
FN057159 breast carcinoma .c 622 to 689 1 to 66       66/67
(98 %)
3 diff
(95.6 %id)
DB234634 trachea .c 671 to 1183 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
FN094628 breast carcinoma .c 696 to 785 1 to 92       92/93
(98 %)
4 diff
(95.7 %id)
TI_1948122933   .c 755 to 1335 691 to 111   fully sequenced,   581/691
(84 %)
7 diff
(99.0 %id)
AL047599 uterus .c 844 to 1401 1 to 566       566/566
(100 %)
8 diff
(98.6 %id)
TI_1948123232   .c 846 to 1335 598 to 110   fully sequenced,   489/598
(81 %)
7 diff
(98.9 %id)
TI_1948122795   .c 861 to 1335 590 to 117   fully sequenced,   474/590
(80 %)
7 diff
(98.9 %id)
TI_1948123086   .c 869 to 1335 576 to 112   fully sequenced,   465/576
(80 %)
7 diff
(98.8 %id)
CB052487 leiomyosarcoma, soft tissue .c 990 to 1614 1 to 625   fully sequenced,   625/625
(100 %)
5 diff
(99.2 %id)
FN047650 breast carcinoma .c 1035 to 1100 1 to 65       65/66
(98 %)
2 diff
(97.0 %id)
BF082683 breast .c 1120 to 1427 310 to 1       310/325
(95 %)
6 diff
(98.2 %id)
AA126844 lung, lung carcinoma .c 1122 to 1607 37 to 522       486/531
(91 %)
3 diff
(99.5 %id)
BM990655 lung, Lung Focal Fibrosis .c 1192 to 1960 2 to 766     Submitted on the opposite strand 765/766
(99 %)
6 diff
(99.3 %id)
AL521420 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .c 1277 to 2045 767 to 1   fully sequenced,   767/767
(100 %)
6 diff
(99.3 %id)
CA450582 Human Lung Epithelial cells, lung .c 1331 to 2095 765 to 1   tiling clone,   765/765
(100 %)
0 diff
(100 %id)
AA608531 lung, lung carcinoma .c 1353 to 1534 202 to 21   AAA   182/182
(100 %)
0 diff
(100 %id)
BQ181878 Knee, Osteoarthritic Cartilage .c 1402 to 2095 694 to 1       694/694
(100 %)
0 diff
(100 %id)
AL047600 uterus .c 1405 to 2092 690 to 1       690/695
(99 %)
2 diff
(99.8 %id)
AI052537   .c 1408 to 1943 1 to 536     Submitted on the opposite strand 536/536
(100 %)
0 diff
(100 %id)
BG413536 pooled .c 1408 to 1666 1 to 259     Submitted on the opposite strand 259/259
(100 %)
0 diff
(100 %id)
AA244279   .c 1409 to 1705 1 to 284       284/284
(100 %)
10 diff
(96.5 %id)
AA244128   .c 1463 to 1764 307 to 6       302/307
(98 %)
0 diff
(100 %id)
AI905375 breast .c 1534 to 1857 1 to 324       324/325
(99 %)
1 diff
(99.7 %id)
DB325032   .c 1535 to 2077 545 to 3       543/548
(99 %)
0 diff
(100 %id)
TI_149273069   .c 1546 to 2079 622 to 89   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 534/831
(64 %)
2 diff
(99.8 %id)
BU675528 lung, Primary Lung Epithelial Cells .c 1546 to 2095 550 to 1       550/558
(98 %)
2 diff
(99.7 %id)
CA311338 Human Lung Epithelial cells, lung .c 1546 to 2095 549 to 1       549/558
(98 %)
1 diff
(99.9 %id)
BG676672 skin, squamous cell carcinoma .c 1569 to 2109 1 to 541       541/937
(57 %)
3 diff
(99.7 %id)
AI745542 Prostate .c 1575 to 2097 523 to 1       523/523
(100 %)
1 diff
(99.9 %id)
BF939339 Prostate .c 1582 to 2084 503 to 1       503/503
(100 %)
0 diff
(100 %id)
CB052486 leiomyosarcoma, soft tissue .c 1584 to 2106 524 to 1   fully sequenced,   524/524
(100 %)
5 diff
(99.1 %id)
BG571470 placenta .c 1617 to 2076 39 to 499   AAA Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base) 461/499
(92 %)
6 diff
(98.8 %id)
CD513770 brain, Pituitary .c 1639 to 2499 28 to 902       875/919
(95 %)
38 diff
(95.9 %id)
BX115300 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1652 to 2093 442 to 1       442/442
(100 %)
0 diff
(100 %id)
DR978572 brain .c 1672 to 2073 1 to 401     Submitted on the opposite strand 401/408
(98 %)
3 diff
(99.3 %id)
CN291428 embryonic stem cells, DMSO-treated H9 cellline .c 1682 to 2077 395 to 2     Submitted on the opposite strand 394/395
(99 %)
0 diff
(100 %id)
AI801718 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1728 to 2080 353 to 1       353/353
(100 %)
0 diff
(100 %id)
H89531 cochlea, ear .c 1749 to 2074 1 to 326   fully sequenced,   326/326
(100 %)
2 diff
(99.4 %id)
H89347 cochlea, ear .c 1879 to 2066 188 to 1   fully sequenced,   188/188
(100 %)
0 diff
(100 %id)
FN133982 breast carcinoma .c 1920 to 2031 1 to 112       112/112
(100 %)
1 diff
(99.2 %id)
AI424293 Prostate .c 1956 to 2081 126 to 1       126/126
(100 %)
0 diff
(100 %id)
AI420123 Prostate .c 1956 to 2081 126 to 1       126/126
(100 %)
0 diff
(100 %id)
BF476423 Prostate .c 1956 to 2081 126 to 1       126/126
(100 %)
0 diff
(100 %id)
BF222303 Prostate .c 1956 to 2081 126 to 1       126/126
(100 %)
1 diff
(99.3 %id)
BU589457 mixed (pool of 40 RNAs) .c 1983 to 2079 1 to 97   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 97/97
(100 %)
2 diff
(98.0 %id)
FN123094 breast carcinoma .c 1999 to 2076 80 to 3     Submitted on the opposite strand 78/83
(93 %)
0 diff
(100 %id)
BE149443 head_neck .c 2088 to 2698 616 to 5   tiling clone, Submitted on the opposite strand 612/616
(99 %)
0 diff
(100 %id)
BG474099 eye, retinoblastoma .c 2103 to 2546 21 to 466       446/661
(67 %)
6 diff
(99.1 %id)
AW205317   .c 2106 to 2504 416 to 18   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 399/406
(98 %)
1 diff
(99.8 %id)
TI_153989120   .c 2106 to 2504 490 to 92   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 399/635
(62 %)
1 diff
(99.9 %id)
AW965245   .c 2336 to 2937 12 to 614       603/616
(97 %)
6 diff
(99.1 %id)
BX104613   .c 2359 to 3017 1 to 658       658/658
(100 %)
4 diff
(99.4 %id)
AA428505   .c 2359 to 2660 1 to 302   fully sequenced,   302/302
(100 %)
0 diff
(100 %id)
CA312169 Human Lung Epithelial cells, lung .c 2359 to 3097 757 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 739/739
(100 %)
0 diff
(100 %id)
BQ447622 Knee, Osteoarthritic Cartilage .c 2362 to 3066 723 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 705/706
(99 %)
2 diff
(99.8 %id)
BE896795 melanotic melanoma, skin .c 2375 to 3071 1 to 693       693/724
(95 %)
12 diff
(98.4 %id)
BE538695 cervix .c 2379 to 3017 1 to 647       647/983
(65 %)
28 diff
(97.2 %id)
AA256456 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2405 to 2572 1 to 168       168/168
(100 %)
2 diff
(98.9 %id)
AA411627 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2406 to 2867 1 to 461   fully sequenced,   461/461
(100 %)
5 diff
(99.0 %id)
TI_159718156   .c 2446 to 3322 964 to 104       861/1046
(82 %)
0 diff
(100 %id)
FN081978 breast carcinoma .c 2507 to 2630 121 to 1     Submitted on the opposite strand 121/121
(100 %)
3 diff
(97.6 %id)
AA479917   .c 2630 to 3065 435 to 1   fully sequenced,   435/435
(100 %)
5 diff
(98.9 %id)
CB852277 Human Lung Epithelial cells, lung .c 2733 to 3322 630 to 41   AAA   590/602
(98 %)
0 diff
(100 %id)
AI277578 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2775 to 3063 293 to 5       289/293
(98 %)
0 diff
(100 %id)
AI276403 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 2786 to 3104 319 to 1       319/319
(100 %)
0 diff
(100 %id)
AA256327 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2797 to 3063 271 to 5       267/271
(98 %)
0 diff
(100 %id)
AA953006 pooled .c 2814 to 3104 291 to 1       291/291
(100 %)
0 diff
(100 %id)
AA406577 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .c 2837 to 3067 231 to 1   fully sequenced,   231/231
(100 %)
3 diff
(98.8 %id)
FN170922 breast carcinoma .c 2927 to 3035 1 to 109       109/109
(100 %)
4 diff
(96.4 %id)
DA278986 corpus callosum .c 3033 to 3608 2 to 577   tiling clone, capped   576/576
(100 %)
0 diff
(100 %id)
DA519948 brain .c 3041 to 3611 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB262560 uterus .c 3131 to 3706 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX642172   .c 3260 to 3909 1 to 650   tiling clone,   650/654
(99 %)
3 diff
(99.6 %id)
TI_157606665   .d 1 to 544 56 to 599 K118X tiling clone, Submitted on the opposite strand 544/600
(90 %)
10 diff
(98.4 %id)
TI_157608593   .d 1 to 703 59 to 760 exact   Submitted on the opposite strand 702/1104
(63 %)
16 diff
(98.6 %id)
AI808539 pooled .d 26 to 529 1 to 504 exact   Submitted on the opposite strand 504/507
(99 %)
1 diff
(99.9 %id)
R34682 placenta .d 70 to 344 1 to 285     Submitted on the opposite strand 285/318
(89 %)
17 diff
(94.7 %id)
EH313109   .d 71 to 134 1 to 64       64/64
(100 %)
1 diff
(98.5 %id)
R81648 placenta .d 71 to 345 1 to 279     Submitted on the opposite strand 279/409
(68 %)
10 diff
(97.6 %id)
R34787 placenta .d 345 to 696 360 to 1   tiling clone, Submitted on the opposite strand 360/360
(100 %)
20 diff
(94.5 %id)
AI273529 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 1 to 378 1 to 378 exact tiling clone, Submitted on the opposite strand 378/378
(100 %)
0 diff
(100 %id)
AK021425 whole embryo, mainly head .f-u 1 to 1831 2 to 1832 exact tiling clone, available from FLJ,   1832/1832
(100 %)
3 diff
(99.9 %id)
AU116906 whole embryo, mainly head .f-u 1 to 694 2 to 698   capped   697/702
(99 %)
10 diff
(98.6 %id)
AU120717 whole embryo, mainly body .f-u 95 to 959 2 to 864   capped   863/863
(100 %)
6 diff
(99.4 %id)
R12348 whole brain .f-u 135 to 566 1 to 447     Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 447/449
(99 %)
26 diff
(94.3 %id)
N47460 multiple sclerosis lesions .f-u 263 to 674 1 to 417       417/491
(84 %)
14 diff
(97.2 %id)
CK431257 eye, lacrimal gland .f-u 282 to 911 1 to 630       630/630
(100 %)
0 diff
(100 %id)
DW443324 Liver .f-u 317 to 480 16 to 179   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 164/181
(90 %)
2 diff
(98.9 %id)
CN360012 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f-u 600 to 1384 1 to 785 exact     785/785
(100 %)
0 diff
(100 %id)
CB053689 leiomyosarcoma, soft tissue .f-u 840 to 1267 9 to 436 exact fully sequenced, Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 428/436
(98 %)
1 diff
(99.8 %id)
BX110543 placenta .f-u 1181 to 1506 1 to 326       326/327
(99 %)
1 diff
(99.7 %id)
N40495 placenta .f-u 1183 to 1477 1 to 296   fully sequenced,   296/296
(100 %)
0 diff
(100 %id)
TI_157602530   .f-u 1216 to 1826 731 to 112   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 620/1050
(59 %)
15 diff
(98.6 %id)
CB053688 leiomyosarcoma, soft tissue .f-u 1237 to 1821 613 to 29   tiling clone, fully sequenced, AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 585/585
(100 %)
1 diff
(99.9 %id)
AU146709 whole embryo, mainly body .f-u 1275 to 1831 561 to 1       561/561
(100 %)
15 diff
(97.4 %id)
AU143871 whole embryo, mainly head .f-u 1286 to 1831 541 to 1       541/541
(100 %)
12 diff
(97.8 %id)
BQ306571 breast .f-u 1325 to 1735 409 to 1       409/409
(100 %)
6 diff
(98.6 %id)
AI148612 placenta .f-u 1346 to 1827 484 to 3       482/484
(99 %)
0 diff
(100 %id)
N47461 multiple sclerosis lesions .f-u 1377 to 1827 454 to 1       454/460
(98 %)
4 diff
(99.2 %id)
CF529482 placenta .f-u 1380 to 1826 465 to 19   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 447/447
(100 %)
0 diff
(100 %id)
R37275 whole brain .f-u 1391 to 1826 457 to 13   AAA Possibly primed on the genome, locally A rich (22/22 A in genome downstream of last aligned base) 445/445
(100 %)
23 diff
(94.9 %id)
AW340609 pooled .f-u 1420 to 1833 418 to 5       414/418
(99 %)
0 diff
(100 %id)
N27086 placenta .f-u 1447 to 1826 384 to 1   fully sequenced,   384/384
(100 %)
5 diff
(98.7 %id)
AI217755 pooled .f-u 1466 to 1826 361 to 1       361/361
(100 %)
0 diff
(100 %id)
AI472942 pooled .f-u 1516 to 1833 320 to 3       318/320
(99 %)
0 diff
(100 %id)
BP375789 uterus .g 1 to 580 1 to 580 exact tiling clone,   580/580
(100 %)
0 diff
(100 %id)
BP342499 stomach mucosa Gene SERTAD4, variant not shown         Suspected internal deletion, this clone was ignored    
BP343253 stomach mucosa Gene SERTAD4, variant not shown         Suspected internal deletion, this clone was ignored    
BF436053 pooled Gene SERTAD4, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C